Key points are not available for this paper at this time.
A decade after the launch of the FDA Sentinel Initiative, it has matured from a pilot program designed to assess potential drug-safety signals in insurance claims into a core component of the agency’s evolving safety surveillance system.
Building similarity graph...
Analyzing shared references across papers
Loading...
Richard Platt
Harvard University
Jeffrey S. Brown
AstraZeneca (United Kingdom)
Melissa A. Robb
United States Food and Drug Administration
New England Journal of Medicine
Harvard University
United States Food and Drug Administration
Harvard Pilgrim Health Care
Building similarity graph...
Analyzing shared references across papers
Loading...
Platt et al. (Wed,) studied this question.
synapsesocial.com/papers/69df47a7d5404a0bea592cae — DOI: https://doi.org/10.1056/nejmp1809643
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: